ISLB 2023


Confirmed Exhibitors

Organized By

Stay up to Date

Confirmed Exhibitors

We would like to thank the following companies for their support.

AEACaP Spanish Association of Lung Cancer Patients

AEACaP is the Spanish Association of Lung Cancer Patients, which offers services and organizes activities to improve patients’ quality of life and also advocates for patients rights and equality. (

Bio-Rad Laboratories

Bio-Rad is among the top five life science companies in the world, providing instruments, software, consumables, reagents and content for various the research areas including cell and molecular biology, protein purification and quantitation, drug discovery and manufacture, food safety, and science education. (

Tell Me More

Health In Code

We aim to establish liquid biopsy analysis with NGS as a standard practice for cancer diagnosis.
Our panel screens for the main biomarkers that are associated with sensitivity to targeted therapy, resistance mechanisms, and clonal evolution. This information plays a critical role in early detection, monitoring and treatment selection. (


At Illumina, our mission is to improve human health by unlocking the power of the genome. Our sequencing by synthesis chemistry is used to generate high-accuracy sequence data in studies around the globe. Our microarrays also provide accurate, high-throughput genotyping for a range of applications. The innovative products that we provide are facilitating breakthroughs in many scientific areas, including oncology, reproductive health, genetic disease, precision medicine, agriculture, microbiology, and beyond. The progress we see being made in genomics inspires us to push the boundaries of what is possible so we can create the next generation of genomics solutions. (

Menarini Silicon Biosystems

We offer unique rare cell technologies that provide clinicians, clinical researchers, and biopharma with access to unparalleled resolution in the study of cells.

CELLSEARCH® and DEPArray™ technologies together provides the most comprehensive cell-based liquid biopsy workflow for enumeration, sorting, and molecular characterization of rare circulating tumor cells with single-cell precision. (

Tell Me More


Through the deployment of GALEAS, our advanced liquid biopsy platform, Nonacus enable decentralised, cost effective and cutting-edge cancer genomics that democratise early cancer detection and monitoring globally. (


OncoHost is a technology company transforming the approach to precision medicine for improved patient outcomes. OncoHost’ proprietary platform, PROphet®, is a plasma-based, proteomic pattern analysis tool whose initial offering in non-small cell lung cancer (NSCLC) uses a single blood sample to guide first-line immunotherapy decision-making. (

Pangaea Oncology

Pangaea Lab, Spain’s first ENAC-accredited pharmacogenetics laboratory, specializes in identifying gene mutations and Next Generation Sequencing in liquid biopsies for oncological patients. Using advanced techniques like real-time PCR, NGS and nCounter, offering precise molecular diagnoses. The team includes experts in Molecular Diagnostic, preclinical oncological research, R&D Diagnostics & Biomarker studies. (


QIAGEN pushes the boundaries of innovation to improve our understanding of DNA, RNA and proteins – the building blocks of life. We enable our customers to unlock valuable insights from any biological sample. Our products for molecular testing serve a wide range of applications from basic research to clinical healthcare. (

Tell Me More


Tempus is making precision medicine a reality by applying AI in healthcare, deriving insights from our expansive library of clinical data and molecular data. We enable physicians to make real-time, data-driven decisions to deliver personalized care and targeted therapies for patients through our analytical machine learning platform that uses the power of artificial intelligence in healthcare. We also work with partners to facilitate discovery, development, and delivery of optimized therapeutic options for patients through distinctive solution sets. (


Tethis S.p.A., a diagnostic company based in Milan (Italy), is introducing See.d, a fully automated liquid biopsy platform that allows for the first time an operator-independent, scalable, high-quality preparation of plasma and cell samples from a single blood draw for multi-omics liquid biopsy. (

Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science. Our Mission is to enable our customers to make the world healthier, cleaner, and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies, or increasing productivity in their laboratories, we are here to support them. (